
Cybersecurity Before MVP vs After Market
How late cybersecurity changes affect medical device architecture, evidence, and remediation scope, without unsupported cost or delay estimates.
Read articleEvery article in our archive in Strategy.
Looking for a quick answer instead? The FDA medical device cybersecurity FAQ covers Section 524B scope, SBOMs, threat models, CR515 and GMLP, deficiencies, and postmarket duties.
Showing 3 of 3 articles in Strategy

How late cybersecurity changes affect medical device architecture, evidence, and remediation scope, without unsupported cost or delay estimates.
Read article
How MedTech teams combine market intelligence and cybersecurity to accelerate growth, de-risk FDA submissions, and win enterprise health-system deals.
Read article
Practical strategies for managing connected medical devices across their lifecycle, aligned with the FDA's Feb 3, 2026 premarket cybersecurity guidance.
Read article30-minute strategy session. No cost, no commitment - just answers from people who've supported 275+ FDA submissions, with zero cybersecurity rejections.